Publication | Open Access
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth
70
Citations
19
References
2020
Year
Our results demonstrated that DLL3-targeted bispecific antibody plus PD-1 inhibition was effective in controlling SCLC growth.
| Year | Citations | |
|---|---|---|
Page 1
Page 1